Back to rounds

Company profile

Anacalypsis Therapeutics

Anacalypsis Therapeutics is a biotechnology company that develops medications and biomarkers for neurodegenerative diseases.

Location
Pikérmi, Attiki, Greece, Europe
Website
anacalypsistherapeutics.com

Latest known funding

Pre-Seed round

Capital
$344.3K
Announced
Sep 21, 2026

Lead investors

Participating investors